Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 24 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapyCrews, K.R.; Monte, A.A.; Huddart, R.; Caudle, K.E.; Kharasch, E.D.; Gaedigk, A.; Dunnenberger, H.M.; Leeder, J.S.; Callaghan, J.T.; Samer, C.F.; Klein, T.E.; Haidar, C.E.; Van Driest, S.L.; Ruano, G.; Sangkuhl, K.; Cavallari, L.H.; Müller, D.J.; Prows, C.A.; Nagy, M.; Somogyi, A.A.; et al.
2021Innate immune and neuronal genetic markers are highly predictive of postoperative pain and morphine patient-controlled analgesia requirements in Indian but not Chinese or Malay hysterectomy patientsBarratt, D.T.; Sia, A.T.; Tan, E.-C.; Somogyi, A.A.
2021Are sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk?Sui, S.X.; Hordacre, B.; Pasco, J.A.
2021Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care usersCations, M.; Lang, C.; Ward, S.A.; Caughey, G.E.; Crotty, M.; Whitehead, C.; Ahern, S.; Maddison, J.; Inacio, M.C.
2021Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipientsSallustio, B.C.; Noll, B.D.; Hu, R.; Barratt, D.T.; Tuke, S.J.; Coller, J.K.; Russ, G.R.; Somogyi, A.A.
2021Medication-related hospital admissions in aged care residentsKalisch Ellett, L.M.; Kassie, G.M.; Caughey, G.E.; Pratt, N.L.; Ramsay, E.N.; Roughead, E.E.
2021Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesJones, N.R.; Nielsen, S.; Farrell, M.; Ali, R.; Gill, A.; Larney, S.; Degenhardt, L.
2021Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 updateKarnes, J.H.; Rettie, A.E.; Somogyi, A.A.; Huddart, R.; Fohner, A.E.; Formea, C.M.; Lee, M.T.M.; Llerena, A.; Whirl-Carrillo, M.; Klein, T.E.; Phillips, E.J.; Mintzer, S.; Gaedigk, A.; Caudle, K.E.; Callaghan, J.T.
2021Treatment of cystic fibrosis: from gene- to cell-based therapiesAllan, K.M.; Farrow, N.; Donnelley, M.; Jaffe, A.; Waters, S.A.
2021Residential medication management reviews in Australian residential aged care facilitiesSluggett, J.K.; Bell, J.S.; Lang, C.; Corlis, M.; Whitehead, C.; Wesselingh, S.L.; Inacio, M.C.